IRIS - Res&Arch Institutional Research Information System - Research & Archive

DI FILIPPO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.669
EU - Europa 1.976
AS - Asia 1.045
SA - Sud America 7
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.663
IE - Irlanda 481
IT - Italia 425
SG - Singapore 419
HK - Hong Kong 243
UA - Ucraina 242
SE - Svezia 226
CN - Cina 183
VN - Vietnam 121
FI - Finlandia 105
FR - Francia 104
RU - Federazione Russa 102
DE - Germania 93
RO - Romania 49
GB - Regno Unito 41
CZ - Repubblica Ceca 35
KR - Corea 24
BE - Belgio 23
JP - Giappone 14
NL - Olanda 14
CH - Svizzera 10
TR - Turchia 9
GR - Grecia 8
LB - Libano 7
IN - India 5
MX - Messico 5
UZ - Uzbekistan 5
AT - Austria 4
EG - Egitto 4
IR - Iran 3
PH - Filippine 3
PL - Polonia 3
SA - Arabia Saudita 3
BR - Brasile 2
CO - Colombia 2
EC - Ecuador 2
EU - Europa 2
KG - Kirghizistan 2
LT - Lituania 2
RS - Serbia 2
AM - Armenia 1
AU - Australia 1
CA - Canada 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 5.705
Salva come PNG Salva come JPEG
Città #
Chandler 512
Dublin 481
Singapore 336
Hong Kong 242
Boardman 229
San Mateo 219
Perugia 171
Santa Clara 147
Altamura 139
Jacksonville 130
Dong Ket 121
Medford 111
Princeton 110
Lawrence 105
Wilmington 93
Andover 86
Ann Arbor 81
Beijing 69
Des Moines 60
Redmond 40
Falls Church 34
Bucharest 33
Los Angeles 30
Helsinki 29
Brno 27
Munich 26
Saint Petersburg 25
Seoul 24
Ashburn 22
Brussels 20
Norwalk 19
Redwood City 18
Woodbridge 17
Tokyo 14
Dallas 13
Moscow 12
Timisoara 12
Den Haag 9
Izmir 9
San Paolo di Civitate 9
Shenzhen 9
Chicago 5
Guangzhou 5
Houston 5
Milan 5
Olomouc 5
Sinnai 5
Foligno 4
Frankfurt am Main 4
Lappeenranta 4
Nizhniy Novgorod 4
Pomezia 4
Terni 4
Verona 4
Chiajna 3
Dasmarinas 3
Giza 3
Paris 3
Wielsbeke 3
Auburn Hills 2
Bishkek 2
Bogotá 2
Changsha 2
Chennai 2
Espoo 2
Fairfield 2
Florence 2
Fremont 2
Gatchina 2
Genoa 2
Groningen 2
Hamburg 2
Mondolfo 2
Nagold 2
New York 2
Padova 2
Prague 2
Prineville 2
Quito 2
Reston 2
Riyadh 2
Shanghai 2
Strongoli 2
Tappahannock 2
Turin 2
Utrecht 2
Washington 2
Alviano 1
Anshan 1
Athens 1
Atlanta 1
Baltimore 1
Bloomfield 1
Bollebygd 1
Brescia 1
Buffalo 1
Böblingen 1
Cambridge 1
Changzhou 1
Chenzhou 1
Totale 4.035
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 152
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 111
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 95
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 84
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 82
Plasticity and repair in the post-ischemic brain 76
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 75
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 75
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 75
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 74
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 73
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 72
Hippocampal epileptogenesis in autoimmune encephalitis 71
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 69
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 69
Mitochondria and the link between neuroinflammation and neurodegeneration. 67
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 66
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 65
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 64
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 64
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 61
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 61
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 60
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 59
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 59
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 59
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 58
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 58
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 58
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 58
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 57
Ischemic stroke injury is mediated by aberrant Cdk5 56
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 56
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. 55
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 55
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 55
A pathophysiological link between dystonia, striatal interneurons and neuropeptide Y 55
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 55
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 55
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 54
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 54
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 53
Distinct levels of dopamine denervation differentially alter striatal synapticplasticity and NMDA receptor subunit composition. 52
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 51
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 51
La disfunzione sessuale nei pazienti con sclerosi multipla: prevalenza e impatto dei trattamenti sintomatici 50
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 50
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 49
Multiple sclerosis and cognition: synaptic failure and network dysfunction 49
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 49
Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS 49
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 49
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 49
Direct and indirect pathways of basal ganglia: a critical reappraisal. 48
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 48
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 48
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 47
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 46
Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis 45
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 45
An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases 45
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 44
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 42
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 42
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 42
Serum neurofilament light chain as a preclinical marker of neurodegeneration 42
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 42
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 41
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 41
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 40
The endocannabinoid system in Parkinson's disease. 40
Teaching NeuroImages: Acute tetraparesis: Mind the brain 40
Lower urinary tract symptoms and urodynamic dysfunctions in clinically isolated syndromes suggestive of multiple sclerosis. 40
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 40
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 39
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 39
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 39
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory. 38
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 38
Infliximab monotherapy for neuro-Behçet's disease: a case report 38
A blood test for Alzheimer's disease: a step forward 37
Sensitization, glutamate, and the link between migraine and fibromyalgia. 36
Neuroscience: Brain's traffic lights. 36
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 36
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 35
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. 35
Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases. 35
Neurofilament light chain as a biomarker in neurological disorders 35
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 35
Dopamine-mediated regulation of corticostriatal synaptic plasticity. 35
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 35
Synaptic plasticity, dopamine and Parkinson's disease: one step ahead. 34
Epidemiologia, patogenesi e genetica. 34
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 34
Plastic abnormalities in experimental Huntington's disease. 34
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 34
Molecular mechanisms underlying levodopa-induced dyskinesia. 34
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 34
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 33
Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. 33
Totale 5.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020239 0 0 0 0 0 17 37 40 43 61 10 31
2020/2021749 8 35 23 38 249 50 45 30 63 25 50 133
2021/20221.041 13 158 34 46 49 31 13 290 21 82 158 146
2022/20231.742 119 373 23 152 124 188 6 58 627 4 51 17
2023/2024918 38 84 33 61 6 2 164 13 122 32 162 201
2024/2025814 27 203 82 106 230 166 0 0 0 0 0 0
Totale 6.024